glp-1 drug test Penn researchers say inconsistent GLP1 use could reduce effectiveness of weight loss GLP-1 weight loss drugs may
Description
In a large Phase 3 clinical trial published in the New England Journal of Medicine, people who took the highest dose of the Wegovy pill lost an average of 16.6 percent of their body weight after 64 weeks
Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk
Certainly, consuming fiber helps you feel fuller for longer
Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension)
Sources: Hedgman, A
